Device Digestive Health

Cortrak

Payments companies reported to CMS as associated with Cortrak. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6,548associated payments (2023-2025)
131clinicians with associated payments
1company reporting

By year

2023 $896
2024 $667
2025 $4,985

Payments reported as associated with Cortrak, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neonatal-Perinatal Medicine $1,035
Neonatal (Nurse Practitioner) $985
Acute Care (Nurse Practitioner) $598
Critical Care Medicine (Clinical Nurse Specialist) $594
Clinical Nurse Specialist $473
Acute Care (Clinical Nurse Specialist) $356

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cortrak

These are the largest totals companies reported as associated with Cortrak. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Janene Fuerch Palo Alto, CA Neonatal-Perinatal Medicine $1,034.96
Jeannie Chan San Francisco, CA Neonatal (Nurse Practitioner) $984.96
Nickeisha Pilgrim Silver Spring, MD Adult Health (Nurse Practitioner) $118.77
Pamela Moss Baltimore, MD Acute Care (Clinical Nurse Specialist) $118.77
Robin Murray Silver Spring, MD Family $118.77
Samantha Young Baltimore, MD Clinical Nurse Specialist $118.77
Elizabeth Corker Frederick, MD Clinical Nurse Specialist $118.77
Alphonsa Rahman Aberdeen, MD Critical Care Medicine (Clinical Nurse Specialist) $118.77
Eugena Baca Bethesda, MD Clinical Nurse Specialist $118.77
Ann Cullen Baltimore, MD Critical Care Medicine (Clinical Nurse Specialist) $118.77

Prescribed Cortrak?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.